# ApTOLL for the Treatment of COVID-19

> **NCT05293236** · PHASE1 · TERMINATED · sponsor: **Macarena Hernández Jiménez** · enrollment: 5 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** ApTOLL
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05293236
- **Lead sponsor:** Macarena Hernández Jiménez
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-14
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of patients due to reduced incidence in the COVID-19 infected population in Spain
- **Last updated:** 2023-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293236, "ApTOLL for the Treatment of COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05293236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*